China Salt Substitute and Stroke Study (SSaSS)
A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)
Sponsor: Centers for Disease Control and Prevention, China
A NA clinical study on Stroke, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention, China and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Feb 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Feb 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Nov 2020 [monthly]
Active Not Recruiting NA
-
May 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
-
May 2019 — May 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention, China
- Changzhi Medical College
- China Medical University, China
- Imperial College London
- Ningxia Medical University
- Northwestern University
- Peking University
- The George Institute
- Xi'an Jiaotong University
For direct contact, visit the study record on ClinicalTrials.gov .